Ticker name:ABTABBOTT LABORATORIES

Country: US-Sector: Healthcare, Industry: Medical - Devices

Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products segment, Abbott provides generic medications designed to treat a wide array of conditions, including pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorders, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine. This segment also supplies the anti-infective clarithromycin, influenza vaccines, and products aimed at regulating colon physiology. The Diagnostic Products division offers a comprehensive suite of diagnostic tools. These include laboratory systems for immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and quantify infectious agents. Additionally, this segment provides point-of-care systems, blood testing cartridges, rapid lateral flow testing products, and specialized molecular point-of-care tests for pathogens such as HIV, SARS-CoV-2, influenza A and B, RSV, and strep A. Its offerings also extend to cardiometabolic test systems, drug and alcohol screening solutions, remote patient monitoring, consumer self-test systems, and sophisticated informatics and automation solutions for laboratory use. The Nutritional Products segment is responsible for delivering nutritional formulations tailored for both pediatric and adult populations. Finally, the Medical Devices segment develops and commercializes rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular ailments. It also supplies diabetes care products and neuromodulation devices designed for the management of chronic pain and movement disorders. Founded in 1888, Abbott Laboratories maintains its corporate headquarters in North Chicago, Illinois.

Market Cap 177B

Last close 101.66$

Key metrics

Largest 20 companies In Medical - Devices

# PositionTickerCompany NameMarket CapLast PriceAction
1ABTABBOTT LABORATORIES177B101.66$
2ISRGINTUITIVE SURGICAL INC125B353.17$
3SYKSTRYKER CORP122B319.14$
4MDTMedtronic plc107B83.29$
5BSXBOSTON SCIENTIFIC CORP65B43.77$
6EWEdwards Lifesciences Corp49B85$
7DXCMDEXCOM INC29B75.69$
8RMDRESMED INC29B198.61$
9ZBHZIMMER BIOMET HOLDINGS, INC.17B89.72$
10SNNSMITH & NEPHEW PLC13B30.43$
11ALGNALIGN TECHNOLOGY INC13B175.05$
12PENPenumbra Inc13B318.01$
13PODDINSULET CORP12B167.37$
14GMEDGLOBUS MEDICAL INC10B76.01$
15GKOSGLAUKOS Corp9.1B155.46$
16BRKRBRUKER CORP8.7B56.17$
17BIOBIO-RAD LABORATORIES, INC.8.1B301.9$
18LIVNLivaNova PLC4.4B79.21$
19IRTCiRhythm Holdings, Inc.3.7B111.37$
20ITGRInteger Holdings Corp3.3B96.09$